• ANNOVERA (MAYNE PHARMA) ANNOVERA is a progestin/estrogen combination hormonal contraceptive indicated for use by females of reproductive potential to prevent pregnancy. It is supplied as a a toroidal shaped (ring), nonbiodegradable, flexible, opaque white vaginal system individually packaged in an aluminum pouch. For more information about ANNOVERA, log in to biosupply.fffenterprises.com
• BIJUVA (MAYNE PHARMA) BIJUVA is combination of an estrogen and progesterone indicated in a woman with a uterus for the treatment of moderate to severe vasomotor symptoms due to menopause. It is supplied as 1 mg/100 mg oval-shaped opaque capsules that are light pink on one side and dark pink on the other side in a blister package of 30 capsules. For more information about BIJUVA, log in to biosupply.fffenterprises.com
• DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS (MAYNE PHARMA) Doxycycline hyclate delayed-release tablets are a tetrocycline-class drug indicated for rickettsial infections; sexually transmitted infections; respiratory tract infections; specific bacterial infections; ophthalmic infections; anthrax, including inhalation anthrax (post-exposure); alternative treatment for selected infections when penicillin is contraindicated; adjunctive therapy in acute intestinal amebiasis and severe acne; and prophylaxis of malaria. It is supplied in 50 mg tablets in a bottle of 120, 75 mg tablets in a bottle of 60, 80 mg tablets in a bottle of 30, 100 mg tablets in a bottle of 100, 150 mg tablets in bottles of 30 and 100, and 200 mg tablets in bottles of 30 and 60. For more information about DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS, log in to biosupply.fffenterprises.com
• FABIOR FOAM (MAYNE PHARMA) FABIOR FOAM is a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. It is supplied in a white to off-white 0.1% (1 mg/g) foam in 50 g and 100 g aluminum cans. For more information about FABIOR FOAM, log in to biosupply.fffenterprises.com
• GLUCAGON (AMPHASTAR PHARMACEUTICALS INC.) GLUCAGON for injection is an antihypoglycemic agent and a gastrointestinal motility inhibitor indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes and as a diagnostic aid for use during radiological examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. For treatment of severe hypoglycemia, it is supplied in a 1 mL single-dose vial with a 1 mL single-dose syringe of sterile water for injection, USP for reconstitution. For use as a diagnostic aid, it is supplied in10 1 mL single-dose vials and in a diagnostic kit with a 1 mL single-dose vial with a 1 mL single-dose vial of sterile water for injection, USP for reconstitution. For more information about GLUCAGON, log in to biosupply.fffenterprises.com
• HALOBETASOL PROPIONATE TOPICAL FOAM (MAYNE PHARMA) HALOBETASOL PROPIONATE TOPICAL FOAM 0.05% is a corticosteroid indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older. It is supplied as 50 g in one can and 100 g in two 50 g cans. For more information about HALOBETASOL PROPIONATE TOPICAL FOAM, log in to biosupply.fffenterprises.com
• IMVEXXY (MAYNE PHARMA) IMVEXXY is an estrogen indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. It is supplied in 4 mcg and 10 mcg small, light pink, tear-shaped inserts for manual placement into the vagina in packages of eight inserts or 18 inserts. For more information about IMVEXXY, log in to biosupply.fffenterprises.com
• LEXETTE TOPICAL FOAM (MAYNE PHARMA) LEXETTE (HALOBETASOL PROPIONATE) TOPICAL FOAM 0.05% is a corticosteroid indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. It is supplied as 50 g in one can and 100 g in two 50 g cans. For more information about LEXETTE TOPICAL FOAM, log in to biosupply.fffenterprises.com
• PRENA1 CHEW (MAYNE PHARMA) PRENA1 CHEW is a prenatal multivitamin for women planning a pregnancy. It is supplied in child-resistant bottles of 30 tablets. For more information about PRENA1 CHEW, log in to biosupply.fffenterprises.com
• VITAPEARL (MAYNE PHARMA) VITAPEARL is a prenatal multivitamin with DHA for women planning a pregnancy, pregnant or nursing. It is supplied in bottles of 30 tablets. For more information about VITAPEARL, log in to biosupply.fffenterprises.com
• NEXTSTELLIS (MAYNE PHARMA) NEXTSTELLIS is a combination of drospirenone, a progestin, and estetrol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. It is supplied in a blister card with 28 6 mm round, bi-convex film-coated tablets in the following order: 1) 24 pink active film-coated tablets containing 3 mg drospirenone and 14.2 mg estetrol embossed with a drop-shaped logo on one side and 2) four white inert film-coated tablets embossed with a drop-shaped logo on one side. For more information about NEXTSTELLIS, log in to biosupply.fffenterprises.com
• CISPLATIN (ACCORD HEALTHCARE, INC) CISPLATIN for injection is a platinum-based drug indicated for the treatment of advanced testicular cancer, advanced ovarian cancer and advanced bladder cancer. It is supplied in single-dose amber vials containing 50 mg of cisplatin as a white to light yellow lyophilized powder for reconstitution. For more information about CISPLATIN, log in to biosupply.fffenterprises.com
• SOLU-MEDROL (PFIZER INJECTABLE) SOLU-MEDROL (methylprednisolone sodium succinate, USP) is indicated for 1) allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions; 2) dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome); 3) endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis; 4) gastrointestinal diseases: to tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis; 5) hematologic disorders: acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, selected cases of secondary thrombocytopenia; 6) miscellaneous: trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy; 7) neoplastic diseases: for the palliative management of leukemias and lymphomas; 8) nervous system: acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy; 9) ophthalmic diseases: sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; 10) renal diseases: to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus; 11) respiratory diseases: berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis; 12) rheumatic disorders: as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus. It is supplied in a 1 g multi-dose vial in packages of 40 mg and 125 mg. For more information about SOLU-MEDROL, log in to biosupply.fffenterprises.com
• TAVABOROLE TOPICAL SOLUTION (MAYNE PHARMA) TAVABOROLE TOPICAL SOLUTION 5% is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. It is supplied in a bottle containing 10 mL of solution with one glass pointed-tip dropper. For more information about TAVABOROLE TOPICAL SOLUTION, log in to biosupply.fffenterprises.com
• TAZAROTENE CREAM (MAYNE PHARMA) TAZAROTENE CREAM 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis and acne vulgaris. It is supplied in a collapsible aluminum tube with a white polypropylene screw cap in 30 g and 60 g sizes. For more information about TAZAROTENE CREAM, log in to biosupply.fffenterprises.com
• TRIAMCINOLONE ACETONIDE OINTMENT (MAYNE PHARMA) TRIAMCINOLONE ACETONIDE OINTMENT 0.5% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It is supplied in a jar containing 430 g. For more information about TRIAMCINOLONE ACETONIDE OINTMENT, log in to biosupply.fffenterprises.com
• REGADENOSON (PFIZER INJECTABLE) REGADENOSON injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. It is supplied as a sterile, preservative-free, clear and colorless solution containing 0.08 mg/mL REGADENOSON in a bundle of 10 5 mL single-dose prefilled plastic Ansyr syringes with a luer-lock fitting. For more information about REGADENOSON, log in to biosupply.fffenterprises.com
• DICLOFENAC EPOLAMINE TOPICAL SYSTEM (YARAL PHARMA) DICLOFENAC EPOLAMINE TOPICAL SYSTEM 1.3% is a nonsteroidal anti-inflammatory drug indicated for the topical treatment of acute pain due to minor strains, sprains and contusions in adults and pediatric patients 6 years and older. It is supplied in resealable envelopes, each containing five topical systems (10 cm x 14 cm) with six envelopes per box.
For more information about DICLOFENAC EPOLAMINE TOPICAL SYSTEM, log in to biosupply.fffenterprises.com
• NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION (XGEN PHARMACEUTICALS DJB) NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION for irrigation is indicated for short-term use (up to 10 days) as a continuous irrigant or rinse in the urinary bladder of abacteriuric patients to help prevent bacteriuria and gram-negative rod septicemia associated with the use of indwelling catheters. It is supplied as 1 mL/ampul in boxes of 10 mL, 50 mL and 20 mL multiple-dose vials in single vial cartons.
For more information about NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION, log in to biosupply.fffenterprises.com
• DOXYCYCLINE (MAYNE PHARMA) DOXYCYCLINE is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. It is supplied in a bottle of 30 beige opaque capsules imprinted with "GLD 40," each containing an amount equivalent to 40 mg of anhydrous doxycycline.
For more information about DOXYCYCLINE, log in to biosupply.fffenterprises.com
• DORYX MPC (MAYNE PHARMA) DORYX MPC is a tetracycline-class drug indicated for the treatment of rickettsial infections; sexually transmitted infections; respiratory tract infections; specific bacterial infections; ophthalmic infections; anthrax, including inhalational anthrax (post-exposure); alternative treatment for selected infections when penicillin is contraindicated; adjunctive therapy in acute intestinal amebiasis and severe acne; and prophylaxis of malaria. The DORYX MPC (doxycycline hyclate delayed-release) 60 mg and 120 mg tablets are white, oval tablets containing yellow pellets and debossed with "D6" on one face and plain on the other. The 60 mg tablets are supplied in bottles of 60 and 120, and the 120 mg tablet is supplied in bottles of 30.
For more information about DORYX MPC, log in to biosupply.fffenterprises.com
• ALTUVIIIO (BIOVERATIV THERAPEUTICS) ALTUVIIIO (antihemophilic factor [recombinant], Fc-VWF-XTEN fusion protein-ehtl) is a recombinant DNA-derived, factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment and control of bleeding episodes and perioperative management of bleeding. It is supplied in kits comprising a single-dose vial containing nominally 250, 500, 750, 1000, 2000, 3000 or 4000 IU of factor VIII potency, a prefilled syringe with 3 mL sterile water for injection and a sterile vial adapter (reconstitution device).
For more information about ALTUVIIIO, log in to biosupply.fffenterprises.com
• ADAPALENE AND BENZOYL PEROXIDE GEL (MAYNE PHARMA) ADAPALENE AND BENZOYL PEROXIDE GEL is a combination of adapalene, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris. It is supplied in a 45 gram pump.
For more information about ADAPALENE AND BENZOYL PEROXIDE GEL, log in to biosupply.fffenterprises.com
• TACROLIMUS OINTMENT (MAYNE PHARMA) TACROLIMUS OINTMENT 0.1% and 0.03% for adults and 0.03% for children aged 2 years to 15 years are indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. It is supplied in 60 gram and 100 gram laminate tubes.
For more information about TACROLIMUS OINTMENT, log in to biosupply.fffenterprises.com
• DAPSONE GEL (MAYNE PHARMA) DAPSONE GEL 7.5% is a sulfone indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. It is supplied in 60 gram and 90 gram airless polypropylene pumps containing a polypropylene bottle with a high-density polyethylene piston.
For more information about DAPSONE GEL, log in to biosupply.fffenterprises.com
• ADAPALENE CREAM (MAYNE PHARMA) ADAPALENE CREAM 0.1% is indicated for the topical treatment of acne vulgaris. It is supplied in a 45 gram tube.
For more information about ADAPALENE CREAM, log in to biosupply.fffenterprises.com
• LIDOCAINE HYDROCHLORIDE 4% (SINTETICA US LLC) LIDOCAINE HYDROCHLORIDE injection 4% is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, and it may be administered by retrobulbar injection to provide anesthesia for ophthalmic surgery. It is supplied in a pack of 10 200 mg/5 mL single-dose ampules.
For more information about LIDOCAINE HYDROCHLORIDE 4%, log in to biosupply.fffenterprises.com
• LIDOCAINE HYDROCHLORIDE 1%/2% (SINTETICA US LLC) LIDOCAINE HYDROCHLORIDE injection 1% and 2% are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal, and by central neural techniques such as lumbar and caudal epidural blocks when the accepted procedures for these techniques as described in standard textbooks are observed. The 1% injection is supplied in a pack of 10 20 mg/2mL, 50 mg/5 mL and 100 mg/10 mL single-dose ampules. The 2% injection is supplied in 40 mg/2 mL, 100 mg/5 mL and 200 mg/10 mL single-dose ampules.
For more information about LIDOCAINE HYDROCHLORIDE 1%/2%, log in to biosupply.fffenterprises.com
• HEPARIN SODIUM (TECHDOW) HEPARIN SODIUM injection is an anticoagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism; prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism; and use as an anticoagulant in blood transfusions, extracorporeal circulation and dialysis procedures. It is supplied in a concentration of 1,000 mL in 2 mL single-dose vials and 1 mL, 10 mL and 30 mL multiple-dose vials; in a concentration of 5,000 mL in 1 mL and 10 mL multiple-dose vials; in a concentration of 10,000 mL in 1 mL and 5 mL multiple-dose vials; and in a concentration of 20,000 mL in 1 mL multiple-dose vials. For more information about HEPARIN SODIUM, log in to biosupply.fffenterprises.com
• METHYLPREDNISOLONE ACETATE (AMNEAL PHARMACEUTICALS) METHYLPREDNISOLONE ACETATE injectable suspension is indicated for 1) control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness and transfusion reactions; 2) dermatologic diseases, including bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus and severe erythema multiforme (Stevens-Johnson syndrome); 3) endocrine disorders, including primary or secondary adrenocortical, congenital adrenal hyperplasia, hypercalcemia associated with cancer and nonsupportive thyroiditis; 4) gastrointestinal diseases, including regional enteritis (systemic therapy) and ulcerative colitis; 5) hematologic disorders, including acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond Blackfan anemia), pure red cell aplasia and select cases of secondary thrombocytopenia; 6) trichinosis with neurologic or myocardial involvement and tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy; 7) neoplastic diseases, including leukemias and lymphomas; 8) cerebral edema associated with primary or metastatic brain tumor or craniotomy; 9) ophthalmic diseases, including sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; 10) to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus; 11) respiratory diseases, including berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias and symptomatic sarcoidosis; and 12) as adjunctive therapy for short-term administration in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis, including juvenile rheumatoid arthritis, and as treatment of dermatomyositis, polymyositis and systemic lupus erythematosus. It is supplied as a white to off-white homogenous suspension in 40 mg/mL and 80 mg/mL single-dose vials in cartons of 25. For more information about METHYLPREDNISOLONE ACETATE, log in to biosupply.fffenterprises.com
• ARTESUNATE (AMIVAS INC.) ARTESUNATE for injection is an antimalarial indicated for the initial treatment of severe malaria in adult and pediatric patients. It is supplied as a white or almost white, sterile, fine crystalline powder for constitution in 110 mg single-dose, clear glass vials sealed with a rubber stopper and an aluminum overseal. For more information about ARTESUNATE, log in to biosupply.fffenterprises.com
• MENQUADFI (SANOFI) MENQUADFI meningococcal (groups A, C, Y, W) conjugate vaccine solution for intramuscular injection is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y for use in individuals 2 years of age and older. It is supplied in a single-dose vial in packages of five vials. For more information about MENQUADFI, log in to biosupply.fffenterprises.com
• PRIORIX (GLAXOSMITHKLINE) PRIORIX (vaccine, live) is indicated for active immunization for the prevention of measles, mumps and rubella in individuals 12 months of age and older. It is supplied in a box containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated syringes of sterile water diluent (packaged without needles). After reconstitution, each vial contains one dose (approximately 0.5 mL) of PRIORIX. For more information about PRIORIX, log in to biosupply.fffenterprises.com
• EPINEPHRINESNAP™-EMS Kit (SNAP MEDICAL INDUSTRIES) EpinephrineSnap™-EMS is an epinephrine convenience kit designed to treat a single episode of an allergic reaction/anaphylaxis. The epinephrine in this kit is a non-selective alpha and beta adrenergic agonist indicated for the emergency treatment of allergic reactions, including anaphylaxis. The kit is supplied with (1) vial of epinephrine injection, (4) alcohol prep pads, (2) 23-gauge, 1-inch safety needles, (2) 1 mL luer lock Epinephrine Syringes™, and (1) instructions for use card. For more information about EPINEPHRINESNAP™-EMS Kit, log in to biosupply.fffenterprises.com
• EPINEPHRINESNAP™-V Kit (SNAP MEDICAL INDUSTRIES) EpinephrineSnap™-V is an epinephrine convenience kit designed to treat a single episode of an allergic reaction/anaphylaxis. The epinephrine in this kit is a non-selective alpha and beta adrenergic agonist indicated for the emergency treatment of allergic reactions, including anaphylaxis. The kit is supplied with (1) vial of epinephrine injection, (4) alcohol prep pads, (3) 23-gauge, 1-inch safety needles, (3) 1 mL luer lock Epinephrine Syringes™, and (1) instructions for use card. For more information about EPINEPHRINESNAP™-V Kit, log in to biosupply.fffenterprises.com
• PREHEVBRIO (VBI VACCINES) PREHEVBRIO (hepatitis B vaccine [recombinant]) is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. It is supplied in a 1.0 mL single-dose vial, or in a package of 10 single dose-vials. For more information about PREHEVBRIO, log in to biosupply.fffenterprises.com
• LANREOTIDE (CIPLA USA) LANREOTIDE injection is a somatostatin analog indicated for 1) the long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy; and 2) the treatment of adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival. It is supplied in strengths of 60 mg/0.2 mL, 90 mg/0.3 mL and 120 mg/0.5 mL in single-dose prefilled syringes. For more information about LANREOTIDE, log in to biosupply.fffenterprises.com
These products can be ordered from FFF Enterprises' BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.
|
